TBILA, controlled by TGF-beta, promotes NSCLC progression in vitro and in vivo by cis-modulating HGAL and positively regulating S100A7/JAB1 signaling (Lu Z. et al., 2018). This evidence concerns the gene COPS5 and non-small cell lung carcinoma.